← Eichor
Study identifier: NCT07525726 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Relationship Between Finger Ratio and Development in Infants

Condition: Infant Developmental Assessment  ·  Sponsor: Nigde Omer Halisdemir University

PhaseN/A
Planned participants80
Who can joinAll sexes, 12 Months to 18 Months
Healthy volunteersYes

About this study

One of the most prominent indicators of prenatal androgen exposure is considered to be the ratio of second and fourth finger lengths (2D:4D). The 2D:4D finger ratio refers to the ratio of the length of the second finger (2D; index finger) and the fourth finger (4D; ring finger). Evidence suggests that 2D:4D is developmentally stable and stabilizes from the second trimester of pregnancy. It has been reported that the 2D:4D ratio correlates positively with estrogen and negatively with testosterone. In both sexes, prenatal testosterone levels are inversely related by a 2D:4D ratio, which does not change with age. Androgens can have direct trophic effects on target cells or indirectly affect neuronal growth through neurotrophic mediators released locally by steroid-sensitive neuronal or glial cells. Prenatal testosterone can have long-term organizational effects on the structure and function of various body systems (e.g., cardiovascular and musculoskeletal systems) that are important for physical activity and exercise.

This description comes directly from the study's public registry record.

Talk to the study team

Rabia ZORLULAR  ·  +5424362082  ·  rabiaeraslan118@gmail.com

Rabia Zorlular  ·  rabiaeraslan118@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Nigde Omer Halisdemir UniversityNiğde, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07525726